drugset / Trial / NCT03981861

Metabolic and Neuro-Endocrine Effect of Treating PCOS in Adolescents

NCT03981861

Phase 2/3 Completed 12 enrolled Children's Mercy Hospital Kansas City
NaSingle-groupOpen-labelTreatment

Summary

To exam in the effect of a combination of low dose Metformin and Spironolactone on functional brain MRI, menstrual regulation and metabolism in adolescents with PCOS.

Timeline

Start
2016-07-02
Primary completion
2018-07-09
Completion
2019-06-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 500 mg Oral
Subject Spironolactone Small molecule 50 mg Oral